Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lloyd Bod

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Cancer Cell|November 1, 2024
Finding the right friends: Stromal composition influences TLS formation in ovarian cancerLloyd Bod
Current Opinion in Immunology|November 15, 2024
B cells spatial organization defines their phenotype and function in cancer "Tell me with whom you consort, and I will tell you who you are" - GoetheLloyd Bod, Shabnam Shalapour
Cell Research|February 23, 2020
Author Correction: The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunityAlexandra Schnell, Lloyd Bod, Asaf Madi, et al.
Cell Research|January 25, 2020
The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunityAlexandra Schnell, Lloyd Bod, Asaf Madi, et al.
Plos One|November 5, 2016
Nitric Oxide Synthase 2 Improves Proliferation and Glycolysis of Peripheral γδ T CellsLaetitia Douguet, Julien Cherfils-Vicini, Lloyd Bod, et al.
Oncoimmunology|September 20, 2018
Inflammation drives nitric oxide synthase 2 expression by γδ T cells and affects the balance between melanoma and vitiligo associated melanomaLaetitia Douguet, Lloyd Bod, Laura Labarthe, et al.
Oncoimmunology|September 14, 2016
Nitric oxide synthase 2 is involved in the pro-tumorigenic potential of γδ17 T cells in melanomaLaetitia Douguet, Lloyd Bod, Renée Lengagne, et al.
Oncotarget|October 28, 2016
Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanomaLudovic Jean Wrobel, Lloyd Bod, Renée Lengagne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2017
IL-4-Induced Gene 1: A Negative Immune Checkpoint Controlling B Cell Differentiation and ActivationLloyd Bod, Laetitia Douguet, Cédric Auffray, et al.
Oncoimmunology|April 14, 2017
IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanomaLloyd Bod, Renée Lengagne, Ludovic Wrobel, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cancer Cell|November 1, 2024
Finding the right friends: Stromal composition influences TLS formation in ovarian cancerLloyd Bod
Current Opinion in Immunology|November 15, 2024
B cells spatial organization defines their phenotype and function in cancer "Tell me with whom you consort, and I will tell you who you are" - GoetheLloyd Bod, Shabnam Shalapour
Cell Research|February 23, 2020
Author Correction: The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunityAlexandra Schnell, Lloyd Bod, Asaf Madi, et al.
Cell Research|January 25, 2020
The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunityAlexandra Schnell, Lloyd Bod, Asaf Madi, et al.
Plos One|November 5, 2016
Nitric Oxide Synthase 2 Improves Proliferation and Glycolysis of Peripheral γδ T CellsLaetitia Douguet, Julien Cherfils-Vicini, Lloyd Bod, et al.
Oncoimmunology|September 20, 2018
Inflammation drives nitric oxide synthase 2 expression by γδ T cells and affects the balance between melanoma and vitiligo associated melanomaLaetitia Douguet, Lloyd Bod, Laura Labarthe, et al.
Oncoimmunology|September 14, 2016
Nitric oxide synthase 2 is involved in the pro-tumorigenic potential of γδ17 T cells in melanomaLaetitia Douguet, Lloyd Bod, Renée Lengagne, et al.
Oncotarget|October 28, 2016
Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanomaLudovic Jean Wrobel, Lloyd Bod, Renée Lengagne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2017
IL-4-Induced Gene 1: A Negative Immune Checkpoint Controlling B Cell Differentiation and ActivationLloyd Bod, Laetitia Douguet, Cédric Auffray, et al.
Oncoimmunology|April 14, 2017
IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanomaLloyd Bod, Renée Lengagne, Ludovic Wrobel, et al.
Pageof 3